New heart valve put to the test in major global study
NCT ID NCT02088554
Summary
This study tested a new surgical heart valve (the Model 400) for people with a narrowed or leaky aortic valve. Over 1,300 patients received the valve and were followed for up to 5 years to see how safe it was and how well it improved their heart function and symptoms. The goal was to gather enough evidence for regulatory approval of this new medical device.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC STENOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aurora Saint Luke's Medical Center
Milwaukee, Wisconsin, 53215-4330, United States
-
Cardiothoracic and Vascular Surgeons (CTVS)
Austin, Texas, 78756-4080, United States
-
Cleveland Clinic
Cleveland, Ohio, 44195-0001, United States
-
Deutsches Herzzentrum München
Munich, München, DE 80636, Germany
-
Erasmus MC
Rotterdam, 3015 CE, Netherlands
-
Guy's & St Thomas' NHS Foundation Trust - St Thomas' Hospital
London, SE1 7EH, United Kingdom
-
Hartford Hospital
Hartford, Connecticut, 06102, United States
-
Herzzentrum Leipzig GmbH
Leipzig, 04289, Germany
-
Houston Methodist Hospital
Houston, Texas, 77030, United States
-
Hôpital Bichat - Claude Bernard
Paris, 75018, France
-
Hôpital Cardiologique du Haut-Lévêque
Bordeaux, 33604, France
-
Inselspital - Universitätsspital Bern
Bern, 3010, Switzerland
-
Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ)
Québec, G1V 4G5, Canada
-
Leids Universitair Medisch Centrum (LUMC)
Leiden, 2333 ZA, Netherlands
-
London Health Sciences Centre - University Campus
London, Ontario, N6A 5A5, Canada
-
Maimonides Medical Center
Brooklyn, New York, 11219, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Medizinische Hochschule Hannover
Hanover, 30625, Germany
-
Minneapolis Heart Institute Foundation
Minneapolis, Minnesota, 55407-1139, United States
-
Montreal Heart Institute
Montreal, Quebec, H1T 1C8, Canada
-
New York-Presbyterian Hospital/Columbia University Medical Center
New York, New York, 10032, United States
-
Oklahoma Heart Hospital
Oklahoma City, Oklahoma, 73135, United States
-
Ospedale San Raffaele - Milano
Milan, 20132, Italy
-
Piedmont Hospital
Atlanta, Georgia, 30309, United States
-
ProMedica Toledo Hospital
Toledo, Ohio, 43606, United States
-
Riverside Methodist Hospital (OhioHealth)
Columbus, Ohio, 43214, United States
-
The Mount Sinai Medical Center
New York, New York, 10029, United States
-
Toronto General Hospital
Toronto, M5G 2C4, Canada
-
Uniklinik Köln
Cologne, Köln, 50924, Germany
-
University of Colorado Hospital
Aurora, Colorado, 80045-2545, United States
-
University of Florida Shands
Gainesville, Florida, 32610, United States
-
University of Maryland Medical Center
Baltimore, Maryland, 21201, United States
-
University of Michigan Cardiovascular Center
Ann Arbor, Michigan, 48109-5853, United States
-
University of Ottawa Heart Institute
Ottawa, Ontario, K1Y 4W7, Canada
-
University of Southern California (USC) University Hospital
Los Angeles, California, 90033-5313, United States
-
University of Washington Medical Center
Seattle, Washington, 98195-0001, United States
-
Universitäts Klinikum Frankfurt - Goethe-Universität
Frankfurt, 60590, Germany
-
UniversitätsSpital Zürich
Zurich, 8091, Switzerland
Conditions
Explore the condition pages connected to this study.